SA-58

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSA-58
Drug Alias NameCoronavirus spike glycoprotein modulator (Sinovac Life Sciences)SA-58
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesSinovac Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A